247 related articles for article (PubMed ID: 15247433)
1. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.
Hwang B; Cho JS; Yeo HJ; Kim JH; Chung KM; Han K; Jang SK; Lee SW
RNA; 2004 Aug; 10(8):1277-90. PubMed ID: 15247433
[TBL] [Abstract][Full Text] [Related]
2. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
3. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.
Kumar PK; Machida K; Urvil PT; Kakiuchi N; Vishnuvardhan D; Shimotohno K; Taira K; Nishikawa S
Virology; 1997 Oct; 237(2):270-82. PubMed ID: 9356339
[TBL] [Abstract][Full Text] [Related]
4. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
[TBL] [Abstract][Full Text] [Related]
5. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
[TBL] [Abstract][Full Text] [Related]
6. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
7. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
[TBL] [Abstract][Full Text] [Related]
8. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
Nishikawa F; Funaji K; Fukuda K; Nishikawa S
Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
10. Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities.
Utama A; Shimizu H; Hasebe F; Morita K; Igarashi A; Shoji I; Matsuura Y; Hatsu M; Takamizawa K; Hagiwara A; Miyamura T
Virology; 2000 Aug; 273(2):316-24. PubMed ID: 10915602
[TBL] [Abstract][Full Text] [Related]
11. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolones inhibit HCV by targeting its helicase.
Khan IA; Siddiqui S; Rehmani S; Kazmi SU; Ali SH
Antivir Ther; 2012; 17(3):467-76. PubMed ID: 22293206
[TBL] [Abstract][Full Text] [Related]
13. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity.
Kim DW; Gwack Y; Han JH; Choe J
Biochem Biophys Res Commun; 1995 Oct; 215(1):160-6. PubMed ID: 7575585
[TBL] [Abstract][Full Text] [Related]
14. Specific RNA aptamers to NS3 protease domain of hepatitis C virus.
Fukuda K; Vishinuvardhan D; Sekiya S; Kakiuchi N; Shimotohno K; Kumar PK; Nishikawa S
Nucleic Acids Symp Ser; 1997; (37):237-8. PubMed ID: 9586087
[TBL] [Abstract][Full Text] [Related]
15. Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase.
Du MX; Johnson RB; Sun XL; Staschke KA; Colacino J; Wang QM
Biochem J; 2002 Apr; 363(Pt 1):147-55. PubMed ID: 11903057
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus NS3 helicase by manoalide.
Salam KA; Furuta A; Noda N; Tsuneda S; Sekiguchi Y; Yamashita A; Moriishi K; Nakakoshi M; Tsubuki M; Tani H; Tanaka J; Akimitsu N
J Nat Prod; 2012 Apr; 75(4):650-4. PubMed ID: 22394195
[TBL] [Abstract][Full Text] [Related]
17. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
18. Internal processing of hepatitis C virus NS3 protein.
Shoji I; Suzuki T; Sato M; Aizaki H; Chiba T; Matsuura Y; Miyamura T
Virology; 1999 Feb; 254(2):315-23. PubMed ID: 9986797
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.
Lam AM; Frick DN
J Virol; 2006 Jan; 80(1):404-11. PubMed ID: 16352565
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]